Reversible Peripheral Neuropathy Associated with Sodium Stibogluconate Therapy for American Cutaneous Leishmaniasis

We describe what we believe is the first documented case of peripheral neuropathy associated with pentavalent antimonial (Sb super(v)) therapy for leishmaniasis.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical infectious diseases 1996-05, Vol.22 (5), p.878-879
Hauptverfasser:	Brummitt, Charles F., Porter, John A. H., Herwaldt, Barbara L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimony Sodium Gluconate - adverse effects Antiprotozoal Agents - adverse effects Biological and medical sciences Brief Reports Cutaneous leishmaniasis Dosage Drug toxicity and drugs side effects treatment Humans Hypesthesia Leishmania braziliensis Leishmaniasis Leishmaniasis, Cutaneous - drug therapy Lesions Male Medical sciences Middle Aged Nervous system diseases Parasitic diseases Peripheral nervous system diseases Peripheral Nervous System Diseases - chemically induced Pharmacology. Drug treatments Preventive medicine Sodium Toxicity: nervous system and muscle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We describe what we believe is the first documented case of peripheral neuropathy associated with pentavalent antimonial (Sb super(v)) therapy for leishmaniasis.
ISSN:	1058-4838 1537-6591
DOI:	10.1093/clinids/22.5.878